PULSED FIELD ABLATION IN PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES - TECHNICAL ASPECTS OF INTERACTION: OBSERVATIONAL CASE STUDY
DOI:
https://doi.org/10.14311/CTJ.2025.1.02Abstract
Pulsed field ablation (PFA) is a new method for treating cardiac arrhythmias. This method uses a sequence of high-voltage pulses to selectively destroy myocardial cells. The procedure can also be performed in patients with a cardiac implantable electronic device (CIED) such as a pacemaker (PCM) or an implantable cardioverter-defibrillator (ICD). The aim was to analyze such interaction of the pulse field and the pacing system. The interaction was assessed in two patients undergoing pulsed-field pulmonary vein isolation for paroxysmal atrial fibrillation in Liberec Regional Hospital. The first patient had a biventricular ICD, the CRT (cardiac resynchronization therapy) type. The second patient had a PCM, the 2D (dual-chamber) type. The signal waveform analysis was performed visually by an expert in real-time via the programmer (using real-time intracardiac electrogram) during each application of pulsed energy in the left atrium. The distance of the ablation catheter from the CIED sensing poles was <10 cm depending on the application in the left or the right pulmonary veins. On the intracardiac ECG, the interference from the PFA was detected by the device as an isolated cardiac event. In ICDs, the interference detection algorithm was also sporadically activated. There was no damage to the CIED electronics during PFA. CIED electronics is protected against high-energy pulsed fields used in these kind of interventions. Impulse interference is not a significant risk for affecting the stimulatory function of the CIED. All CIEDs have limits in signal processing as they are targeting the heart signal frequency range. The signal envelope from these high-frequency applications can be seen on the intracardiac ECGs. The signal processing parameters of CIEDs and the effect on pacing function may vary across different systems.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jan Morava, Tomáš Roubíček, Aleš Richter

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of the first publication with the work simultaneously licensed under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in CTJ.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website or ResearchGate) prior to and during the submission process, as it can lead to productive exchanges.
CTJ requires that all of the content of the manuscript has been created by its respective authors or that permission to use a copyrighted material has been obtained by the authors before submitting the manuscript to CTJ. CTJ requires that authors have not used any copyrighted material illegally, as for example a picture from another journal or book, a photo, etc. It is the author’s responsibility to use only materials not violating the copyright law. When in doubt, CTJ may ask the authors to supply the pertinent permission or agreement about the use of a copyrighted material.
The opinions expressed in CTJ articles are those of authors and do not necessarily reflect the views of the publishers or the Czech Society for Biomedical Engineering and Medical Informatics.